10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
22.62
-0.52 (-2.25%)
At close: Mar 3, 2026, 4:00 PM EST
22.14
-0.48 (-2.12%)
After-hours: Mar 3, 2026, 6:49 PM EST
10x Genomics Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for 10x Genomics stock have an average target of 17.18, with a low estimate of 6.50 and a high estimate of 25. The average target predicts a decrease of -24.05% from the current stock price of 22.62.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for 10x Genomics stock from 14 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 5 | 6 | 8 | 9 | 9 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 12 | 13 | 13 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $20 → $25 | Strong Buy | Maintains | $20 → $25 | +10.52% | Mar 2, 2026 |
| UBS | UBS | Hold Maintains $14 → $20 | Hold | Maintains | $14 → $20 | -11.58% | Feb 20, 2026 |
| Stifel | Stifel | Strong Buy Maintains $15 → $20 | Strong Buy | Maintains | $15 → $20 | -11.58% | Feb 13, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $18 → $19 | Hold | Maintains | $18 → $19 | -16.00% | Feb 13, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains $22 → $20 | Hold | Maintains | $22 → $20 | -11.58% | Jan 27, 2026 |
Financial Forecast
Revenue This Year
619.88M
from 642.82M
Decreased by -3.57%
Revenue Next Year
665.27M
from 619.88M
Increased by 7.32%
EPS This Year
-0.96
from -0.35
EPS Next Year
-0.71
from -0.96
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 655.2M | 721.4M | |||
| Avg | 619.9M | 665.3M | |||
| Low | 595.5M | 622.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.9% | 16.4% | |||
| Avg | -3.6% | 7.3% | |||
| Low | -7.4% | 0.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.56 | -0.16 | |||
| Avg | -0.96 | -0.71 | |||
| Low | -1.18 | -0.97 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.